About Patrik Schmidle
Patrik Schmidle is president and CEO of CARI Health. CARI Health helps clinicians personalize methadone dosing. His team includes clinicians and biochemical and electrical engineers. Earlier, he worked at startups, mid-sized private businesses and public companies, mainly in B2B software and market research. He took varied roles to learn all parts of business while aiming to become an entrepreneur. After participating in six acquisitions as an employee, he founded CARI Health after seeing a close family member struggle with opioids.
He was CARI Therapeutics' CEO and co-founder, as well as a project co-principal investigator. The project sought a biosensor to detect opioids in patients in recovery. He led the work. It received partial funding from a $235,000 Phase I grant from the National Institute of Drug Abuse. He also led an earlier National Science Foundation-funded effort that created an alcohol-monitoring platform.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Patrik Schmidle in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Patrik Schmidle works with at each company, as listed on that company's latest Form D.
